Aquaculture is essential for global food security. Yet disease outbreaks in Nile tilapia ( Oreochromis niloticus ) farms cause considerable economic losses and environmental damage. Overuse of antibiotics has exacerbated antimicrobial resistance (AMR), necessitating sustainable alternatives such as probiotics. This review synthesizes data from 79 studies published between 2015 and 2024 demonstrating that probiotics, particularly the Bacillus and Lactobacillus groups, which represent 52% and 24% of studies, respectively, effectively combat dominant pathogens, including Streptococcus and Aeromonas , studied by 48% and 36% of studies, respectively. Probiotics act by immune modulation in 57% of cases, by production of antimicrobial compounds in 21% of cases, and by competitive exclusion in 12% of cases. Feed‐based delivery was used in 98% of studies, highlighting its practicality in farm settings. Compared with antibiotics, probiotics reduce the risks of AMR and environmental toxicity, although challenges such as strain specificity persist. Field‐scale validation and research on anti‐inflammatory effects (3% of studies) are needed to optimize their use. These findings highlight probiotics as a viable and environmentally responsible alternative for disease management in Nile tilapia aquaculture.
21 October 2026 in Environmental Microbiology Reports
The use of probiotics is a promising strategy to enhance fish health and sustainability in aquaculture as alternatives to antibiotics. This study applied a systematic multi‐criteria screening approach to identify autochthonous probiotic candidates from the intestinal microbiota of healthy red tilapia ( Oreochromis sp.). A total of 26 culturable bacterial isolates were recovered and evaluated for antimicrobial activity against major fish pathogens ( Aeromonas hydrophila , Streptococcus agalactiae and Streptococcus iniae ), safety, tolerance to simulated gastrointestinal conditions, adhesion‐related properties, enzymatic activities and environmental robustness. Only a small subset of isolates exhibited broad‐spectrum antimicrobial activity and satisfied subsequent safety and functional criteria. Based on integrated performance, three isolates were shortlisted for advanced evaluation, of which two were retained for molecular identification. The selected isolates were identified by 16S rRNA gene sequencing as Pseudomonas aeruginosa PA4 (PA4) and Bacillus sp. BA4P (BA4P). Both strains demonstrated tolerance to gastrointestinal stress, measurable adhesion‐related hydrophobicity, diverse enzymatic activities and stability under varying temperature and salinity conditions. These findings provide a robust framework for screening host‐associated probiotics and support the further evaluation of PA4 and BA4P as potential candidates for sustainable tilapia aquaculture.